Dedong Cao

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 9

Top Topics

Peritoneal Dialysis

Patient Reported

Epidermal Growth Factor Receptor

Long Non Coding Rna

Top Venues

Journal of oncology

International journal of molecular sciences

Cancer management and research

Therapeutic advances in medical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaohong Liu, Dedong Cao, Hui Liu, XiaoKang Ke, Xin Liu, Ximing Xu
Comparative analysis of upper aerodigestive tract and non-upper aerodigestive tract in NK/T-cell lymphoma. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
Huilin Xu, Dedong Cao, Dingjie Zhou, Anbing He, Wei Ge, Ximing Xu
Assessing Potential Factors Influencing the Efficacy of Immune Checkpoint Inhibitors with Radiation in Advanced Non-Small-Cell Lung Cancer Patients: A Systematic Review and Meta-Analysis. Journal of oncology 2023 (2023)
Huilin Xu, Dedong Cao, Dingjie Zhou, Anbing He, Wei Ge, Ximing Xu
Assessing Potential Factors Influencing the Efficacy of Immune Checkpoint Inhibitors with Radiation in Advanced Non-Small-Cell Lung Cancer Patients: A Systematic Review and Meta-Analysis. Journal of oncology 2023 (2023)
Juan Feng, Jun Ren, Xiuqi Li, Xue Zhang, Qingfeng Yang, Zankai Wu, Le Cui, Lingxia Liao, Yiping Gong, Dedong Cao
Phagocytosis-Regulators-Based Signature to Predict the Prognosis and Chemotherapy Resistance for Breast Cancer Patients. International journal of molecular sciences 23 (18) (2022)
Yang Shen, Nan Zhao, Nan Zhao, Xinyao Hu, Xiaoqin He, Yangtao Xu, Jiayu Chen, Wenliang Chen, Xin Liu, Zhuolin Zhou, Dedong Cao, Ximing Xu
Tumor-Suppressive and Oncogenic Roles of microRNA-149-5p in Human Cancers. International journal of molecular sciences 23 (18) (2022)
Xiaohong Liu, Dedong Cao, Hui Liu, Dong Ke, Xiaokang Ke, Ximing Xu
Clinical Features Analysis and Survival Nomogram of Primary Small Intestinal Diffuse Large B-Cell Lymphoma. Cancer management and research 14 (2022)
Huilin Xu, Dedong Cao, Fangfang Jie, Anbing He, Wei Ge
The efficacy and safety of anlotinib for subsequent line treatment of small cell lung cancer: a systematic review and meta-analysis. Tumori (2022)
Qiang Xu, Dedong Cao, Bin Fang, Siqi Yan, Yu Hu, Tao Guo
Immune-related gene signature predicts clinical outcomes and immunotherapy response in acute myeloid leukemia. Cancer medicine 11 (17) (2022)
Huilin Xu, Ximing Xu, Wei Ge, Jinju Lei, Dedong Cao
The association between immune-related adverse events and the prognosis of solid cancer patients treated with immunotherapy: a systematic review and meta-analysis. Therapeutic advances in medical oncology 12 (2020)